title: Bone marrow derived stem cells in joint and bone diseases: a concise review.
abstract: Stem cells have huge applications in the field of tissue engineering and regenerative medicine. Their use is currently not restricted to the life-threatening diseases but also extended to disorders involving the structural tissues, which may not jeopardize the patients' life, but certainly influence their quality of life. In fact, a particularly popular line of research is represented by the regeneration of bone and cartilage tissues to treat various orthopaedic disorders. Most of these pioneering research lines that aim to create new treatments for diseases that currently have limited therapies are still in the bench of the researchers. However, in recent years, several clinical trials have been started with satisfactory and encouraging results. This article aims to review the concept of stem cells and their characterization in terms of site of residence, differentiation potential and therapeutic prospective. In fact, while only the bone marrow was initially considered as a "reservoir" of this cell population, later, adipose tissue and muscle tissue have provided a considerable amount of cells available for multiple differentiation. In reality, recently, the so-called "stem cell niche" was identified as the perivascular space, recognizing these cells as almost ubiquitous. In the field of bone and joint diseases, their potential to differentiate into multiple cell lines makes their application ideally immediate through three main modalities: (1) cells selected by withdrawal from bone marrow, subsequent culture in the laboratory, and ultimately transplant at the site of injury; (2) bone marrow aspirate, concentrated and directly implanted into the injury site; (3) systemic mobilization of stem cells and other bone marrow precursors by the use of growth factors. The use of this cell population in joint and bone disease will be addressed and discussed, analysing both the clinical outcomes but also the basic research background, which has justified their use for the treatment of bone, cartilage and meniscus tissues.
authors.affiliation: Department of Orthopaedics and Traumatology, University of Torino, Torino, Italy, antonio.marmotti@inwind.it.
authors.forename: Antonio
authors.initials: A
authors.lastname: Marmotti
authors.forename: Laura
authors.initials: L
authors.lastname: de Girolamo
authors.forename: Davide Edoardo
authors.initials: DE
authors.lastname: Bonasia
authors.forename: Matteo
authors.initials: M
authors.lastname: Bruzzone
authors.forename: Silvia
authors.initials: S
authors.lastname: Mattia
authors.forename: Roberto
authors.initials: R
authors.lastname: Rossi
authors.forename: Angela
authors.initials: A
authors.lastname: Montaruli
authors.forename: Federico
authors.initials: F
authors.lastname: Dettoni
authors.forename: Filippo
authors.initials: F
authors.lastname: Castoldi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Peretti
mesh_terms: D001847:Bone Diseases / Q000628:therapy*; D001861:Bone Regeneration; D006801:Humans; D007592:Joint Diseases / Q000628:therapy*; D045164:Mesenchymal Stem Cell Transplantation; D044968:Regenerative Medicine / Q000639:trends; D023822:Tissue Engineering / Q000639:trends